glutamine and pf 573228

glutamine has been researched along with pf 573228 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, K; Eguchi, S; Fujii, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M	1

Other Studies

1 other study(ies) available for glutamine and pf 573228

Article	Year
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro. International journal of oncology, 2017, Volume: 50, Issue:4 Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases	2017

Article

Year

Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.

International journal of oncology, 2017, Volume: 50, Issue:4

Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases

2017